Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion type Assertion NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_head.
- NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion description "[Also, the killing efficiency of CD16(+) lymphocytes was influenced by 158 V/F polymorphism of Fc gamma RIII (CD16), whereas variations of CD247 on NK cells were consistent with trends between ADCC before and after therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_provenance.
- NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion evidence source_evidence_literature NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_provenance.
- NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion SIO_000772 18089830 NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_provenance.
- NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion wasDerivedFrom befree-20140225 NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_provenance.
- NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_assertion wasGeneratedBy ECO_0000203 NP299537.RAviJDjyYTy8v6UIXEVi5u9cId5kcUjskUWQmK2NBMVRk130_provenance.